SNY
SanofiHealthcare · $99.1B market cap
Verdict
Share price
$39.92
close of Oct 3, 2026
Fair value
$49.83
Sticker Price
Payback Price
$19.93
buy price
SNY is Undervalued: at $39.92 it trades 20% below its fair value of $49.83. Its buy price (Payback Price) is $19.93, 50% below today's price. Business quality is limited: none of the 5 key numbers clears the 10% bar.
How we valued it
Dividend Discount Model. It has paid a dividend for 10+ years in a row, raised it most years, and yields over 2%. For a steady payer like this, the dividend is the best guide to value.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow SNY
Get notified when it reaches its buy price of $19.93. Free.
Create a free accountSuperinvestors
4 of the investors we track hold SNY. In Q2 2026, 2 added and 1 trimmed. Who we track
About Sanofi
Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core divisions: Pharmaceuticals, Vaccines, and Consumer Healthcare. Within its Pharmaceutical segment, Sanofi…
Drug Manufacturers - General
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works